Selected research
Industry Research
Lung Surfactants Industry Research Report 2026
Market perspective
The global Lung Surfactants market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lung Surfactants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lung Surfactants is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lung Surfactants is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lung Surfactants include Aviva Systems Biology Corporation, Chiesi Farmaceutici, Lyomark Pharma, ONY Biotech, Windtree Therapeutics and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lung Surfactants market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lung Surfactants Market by Company
Aviva Systems Biology Corporation
Chiesi Farmaceutici
Lyomark Pharma
ONY Biotech
Windtree Therapeutics
AbbVie
Lung Surfactants Segment by Type
Intratracheal
Injectable
Lung Surfactants Segment by Application
Special Clinic
Hospital
Recovery Center
Lung Surfactants Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Surfactants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lung Surfactants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Surfactants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lung Surfactants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lung Surfactants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lung Surfactants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intratracheal
- Injectable
Applications
- Special Clinic
- Hospital
- Recovery Center
Companies covered
- Aviva Systems Biology Corporation
- Chiesi Farmaceutici
- Lyomark Pharma
- ONY Biotech
- Windtree Therapeutics
- AbbVie
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lung Surfactants Market Size (2021-2032)
- 2.2.2 Global Lung Surfactants Sales (2021-2032)
- 2.2.3 Global Lung Surfactants Market Average Price (2021-2032)
- 2.3 Lung Surfactants by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Intratracheal
- 2.3.3 Injectable
- 2.4 Lung Surfactants by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Special Clinic
- 2.4.3 Hospital
- 2.4.4 Recovery Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lung Surfactants Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lung Surfactants Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lung Surfactants Revenue of Manufacturers (2021-2026)
- 3.4 Global Lung Surfactants Average Price by Manufacturers (2021-2026)
- 3.5 Global Lung Surfactants Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lung Surfactants, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lung Surfactants, Product Type & Application
- 3.8 Global Manufacturers of Lung Surfactants, Established Date
- 3.9 Global Lung Surfactants Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aviva Systems Biology Corporation
- 4.1.1 Aviva Systems Biology Corporation Company Information
- 4.1.2 Aviva Systems Biology Corporation Business Overview
- 4.1.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aviva Systems Biology Corporation Lung Surfactants Product Portfolio
- 4.1.5 Aviva Systems Biology Corporation Recent Developments
- 4.2 Chiesi Farmaceutici
- 4.2.1 Chiesi Farmaceutici Company Information
- 4.2.2 Chiesi Farmaceutici Business Overview
- 4.2.3 Chiesi Farmaceutici Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Chiesi Farmaceutici Lung Surfactants Product Portfolio
- 4.2.5 Chiesi Farmaceutici Recent Developments
- 4.3 Lyomark Pharma
- 4.3.1 Lyomark Pharma Company Information
- 4.3.2 Lyomark Pharma Business Overview
- 4.3.3 Lyomark Pharma Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lyomark Pharma Lung Surfactants Product Portfolio
- 4.3.5 Lyomark Pharma Recent Developments
- 4.4 ONY Biotech
- 4.4.1 ONY Biotech Company Information
- 4.4.2 ONY Biotech Business Overview
- 4.4.3 ONY Biotech Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ONY Biotech Lung Surfactants Product Portfolio
- 4.4.5 ONY Biotech Recent Developments
- 4.5 Windtree Therapeutics
- 4.5.1 Windtree Therapeutics Company Information
- 4.5.2 Windtree Therapeutics Business Overview
- 4.5.3 Windtree Therapeutics Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Windtree Therapeutics Lung Surfactants Product Portfolio
- 4.5.5 Windtree Therapeutics Recent Developments
- 4.6 AbbVie
- 4.6.1 AbbVie Company Information
- 4.6.2 AbbVie Business Overview
- 4.6.3 AbbVie Lung Surfactants Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AbbVie Lung Surfactants Product Portfolio
- 4.6.5 AbbVie Recent Developments
5 Global Lung Surfactants Market Scenario by Region
- 5.1 Global Lung Surfactants Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lung Surfactants Sales by Region: 2021-2032
- 5.2.1 Global Lung Surfactants Sales by Region: 2021-2026
- 5.2.2 Global Lung Surfactants Sales by Region: 2027-2032
- 5.3 Global Lung Surfactants Revenue by Region: 2021-2032
- 5.3.1 Global Lung Surfactants Revenue by Region: 2021-2026
- 5.3.2 Global Lung Surfactants Revenue by Region: 2027-2032
- 5.4 North America Lung Surfactants Market Facts & Figures by Country
- 5.4.1 North America Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lung Surfactants Sales by Country (2021-2032)
- 5.4.3 North America Lung Surfactants Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lung Surfactants Market Facts & Figures by Country
- 5.5.1 Europe Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lung Surfactants Sales by Country (2021-2032)
- 5.5.3 Europe Lung Surfactants Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Lung Surfactants Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lung Surfactants Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lung Surfactants Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lung Surfactants Market Facts & Figures by Country
- 5.7.1 South America Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lung Surfactants Sales by Country (2021-2032)
- 5.7.3 South America Lung Surfactants Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Lung Surfactants Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lung Surfactants Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lung Surfactants Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lung Surfactants Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lung Surfactants Sales by Type (2021-2032)
- 6.1.1 Global Lung Surfactants Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lung Surfactants Sales Market Share by Type (2021-2032)
- 6.2 Global Lung Surfactants Revenue by Type (2021-2032)
- 6.2.1 Global Lung Surfactants Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lung Surfactants Revenue Market Share by Type (2021-2032)
- 6.3 Global Lung Surfactants Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lung Surfactants Sales by Application (2021-2032)
- 7.1.1 Global Lung Surfactants Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lung Surfactants Sales Market Share by Application (2021-2032)
- 7.2 Global Lung Surfactants Revenue by Application (2021-2032)
- 7.2.1 Global Lung Surfactants Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lung Surfactants Revenue Market Share by Application (2021-2032)
- 7.3 Global Lung Surfactants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lung Surfactants Value Chain Analysis
- 8.1.1 Lung Surfactants Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lung Surfactants Production Mode & Process
- 8.2 Lung Surfactants Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lung Surfactants Distributors
- 8.2.3 Lung Surfactants Customers
9 Global Lung Surfactants Analyzing Market Dynamics
- 9.1 Lung Surfactants Industry Trends
- 9.2 Lung Surfactants Industry Drivers
- 9.3 Lung Surfactants Industry Opportunities and Challenges
- 9.4 Lung Surfactants Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst